Skip to content

DIADEMA PARTNERS LP

Follow

13F filer, CIK 2026172, MORRISTOWN, NJ

DIADEMA PARTNERS LP reported $390,971,772 across 130 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14. Its ten largest share positions make up 56.26% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001892688-25-000193

Period
2025-09-30
Reported value
$391M
Holdings
130
Top 10 weight
56.26%
New
75
Sold out
40

Largest buys vs the previous quarter

SecurityShares changeApprox. value
REGNadded+24,553$13.8M
INDIVIOR PLCnew+254,252$6.13M
BMYnew+130,000$5.86M
ASNDnew+27,572$5.48M
ALNYnew+10,000$4.56M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AMGNexited-52,100-$14.5M
LLYexited-14,816-$11.5M
TGTXreduced-310,700-$11.2M
JAZZreduced-81,333-$10.7M
NBIXreduced-56,288-$7.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001892688-25-000193, largest first. % of portfolio is the value over $143,559,417, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 29,828 shares; 2025Q2: 5,607 shares; 2025Q3: 30,160 shares 30,160$17M11.81%+24,553Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 71,988 shares; 2025Q1: 93,002 shares; 2025Q2: 284,152 shares; 2025Q3: 177,330 shares 177,330$12M8.35%-106,822Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 52,877 shares; 2025Q2: 192,877 shares; 2025Q3: 212,877 shares 212,877$11.5M8.03%+20,000Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 10,000 shares; 2025Q1: 92,385 shares; 2025Q2: 198,285 shares; 2025Q3: 218,285 shares 218,285$7.86M5.48%+20,000Timeline
INDIVIOR PLCINDIVIOR PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 254,252 shares 254,252$6.13M4.27%new
BMYBRISTOL-MYERS SQUIBB COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 160,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 130,000 shares 130,000$5.86M4.08%newTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 25,276 shares; 2025Q1: 8,321 shares; 2025Q2: not reported; 2025Q3: 27,572 shares 27,572$5.48M3.82%newTimeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 62,247 shares; 2025Q2: 94,042 shares; 2025Q3: 37,754 shares 37,754$5.3M3.69%-56,288Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 104,121 shares; 2025Q2: 197,468 shares; 2025Q3: 193,689 shares 193,689$5.09M3.55%-3,779Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 13,115 shares; 2025Q2: not reported; 2025Q3: 10,000 shares 10,000$4.56M3.18%newTimeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 96,984 shares; 2025Q2: 104,384 shares; 2025Q3: 124,384 shares 124,384$4.52M3.15%+20,000Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 75,000 shares 75,000$4.27M2.97%newTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 41,620 shares 41,620$3.51M2.45%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 76,185 shares; 2025Q3: 51,185 shares 51,185$3.4M2.37%-25,000Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 14,719 shares; 2025Q1: 87,189 shares; 2025Q2: 104,473 shares; 2025Q3: 23,140 shares 23,140$3.05M2.12%-81,333Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 31,400 shares 31,400$2.88M2%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 79,079 shares; 2025Q3: 59,079 shares 59,079$2.76M1.92%-20,000Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 50,620 shares; 2025Q1: 40,000 shares; 2025Q2: 10,572 shares; 2025Q3: 64,250 shares 64,250$2.55M1.78%+53,678Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 50,370 shares; 2025Q1: 56,098 shares; 2025Q2: 259,852 shares; 2025Q3: 323,159 shares 323,159$2.43M1.69%+63,307Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 400,000 shares 400,000$2.2M1.54%newTimeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 47,805 shares; 2025Q1: 207,883 shares; 2025Q2: 371,448 shares; 2025Q3: 60,748 shares 60,748$2.19M1.53%-310,700Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 72,079 shares 72,079$2.16M1.51%newTimeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 120,000 shares 120,000$1.82M1.26%newTimeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 50,000 shares; 2025Q1: 76,220 shares; 2025Q2: 150,000 shares; 2025Q3: 90,000 shares 90,000$1.8M1.25%-60,000Timeline
PCRXPACIRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 38,926 shares; 2025Q2: 58,926 shares; 2025Q3: 58,926 shares 58,926$1.52M1.06%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 90,000 shares; 2025Q1: 392,213 shares; 2025Q2: 392,213 shares; 2025Q3: 97,813 shares 97,813$1.4M0.98%-294,400Timeline
NVONOVO-NORDISK A SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 24,618 shares; 2025Q2: not reported; 2025Q3: 25,000 shares 25,000$1.39M0.97%newTimeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares 50,000$1.38M0.96%newTimeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,000 shares 100,000$1.36M0.95%newTimeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 30,000 shares 30,000$1.31M0.91%newTimeline
MIND MEDICINE MINDMED INCMIND MEDICINE MINDMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 4,710 shares; 2025Q1: not reported; 2025Q2: 158,536 shares; 2025Q3: 105,891 shares 105,891$1.25M0.87%-52,645
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 442,520 shares; 2025Q1: 565,975 shares; 2025Q2: 403,922 shares; 2025Q3: 349,789 shares 349,789$1.24M0.86%-54,133Timeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 212,475 shares 212,475$1.14M0.79%newTimeline
SUPNSUPERNUS PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 22,348 shares 22,348$1.07M0.74%newTimeline
CPRXCATALYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares 50,000$985K0.69%newTimeline
Reviva Pharmaceuticals Hold…Reviva Pharmaceuticals Holdings I…Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 650,723 shares; 2025Q2: 2,735,457 shares; 2025Q3: 2,506,921 shares 2,506,921$924K0.64%-228,536
ARCTARCTURUS THERAPEUTICS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 48,811 shares 48,811$900K0.63%newTimeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: 180,000 shares; 2025Q2: 185,830 shares; 2025Q3: 85,830 shares 85,830$785K0.55%-100,000Timeline
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 74,753 shares 74,753$608K0.42%newTimeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 185,286 shares 185,286$591K0.41%newTimeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares 20,000$517K0.36%newTimeline
AYTUAYTU BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 272,670 shares 272,670$513K0.36%newTimeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 315,519 shares 315,519$511K0.36%newTimeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares 300,000$429K0.3%newTimeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 239,019 shares; 2025Q1: 456,546 shares; 2025Q2: 266,023 shares; 2025Q3: 136,023 shares 136,023$403K0.28%-130,000Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 158,023 shares; 2025Q1: 207,694 shares; 2025Q2: 157,694 shares; 2025Q3: 157,694 shares 157,694$336K0.23%0Timeline
PYXSPYXIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 150,000 shares 150,000$333K0.23%newTimeline
PTHSPELTHOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,498 shares 10,498$294K0.2%newTimeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 53,985 shares; 2025Q3: 9,189 shares 9,189$276K0.19%-44,796Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 374,423 shares; 2025Q1: 669,803 shares; 2025Q2: 702,135 shares; 2025Q3: 136,488 shares 136,488$274K0.19%-565,647Timeline
NEUPNEUPHORIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 21,452 shares 21,452$253K0.18%newTimeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares 50,000$244K0.17%newTimeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 187,739 shares 187,739$244K0.17%newTimeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: 505,778 shares; 2025Q1: 426,346 shares; 2025Q2: 43,616 shares; 2025Q3: 43,616 shares 43,616$228K0.16%0Timeline
VTYXVENTYX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 71,204 shares 71,204$221K0.15%newTimeline
PRTCYPURETECH HEALTH PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 7,324 shares; 2025Q3: 7,324 shares 7,324$135K0.09%0Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,295 shares 3,295$101K0.07%newTimeline
TVRDTVARDI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,185 shares 2,185$85.1K0.06%newTimeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 11,300 shares 11,300$15.8K0.01%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
QUREUNIQURE NV SHSput300,000$17.5Mnew
SPYSTATE STR SPDR S&P 500 ETF T SHSput20,000$13.3Mnew
JAZZJAZZ PHARMACEUTICALS PLC Stockcall100,000$13.2M+50,000
VKTXVIKING THERAPEUTICS INC COMcall405,100$10.6Mnew
AGIOAGIOS PHARMACEUTICALS INC COMcall222,100$8.92M+100,000
RNAMAVIDITY BIOSCIENCES INC Stockcall200,100$8.72Mnew
INCYINCYTE CORP Stockcall100,000$8.48Mnew
NTLAINTELLIA THERAPEUTICS INC COMcall470,200$8.12Mnew
BMYBRISTOL-MYERS SQUIBB CO COMcall180,000$8.12Mnew
LLYELI LILLY & CO COMput10,000$7.63M-10,700
CRSPCRISPR THERAPEUTICS AG Stockcall112,000$7.26M0
BBIOBRIDGEBIO PHARMA INC COMcall131,400$6.82M0
SLNOSOLENO THERAPEUTICS INC COMput100,000$6.76Mnew
JAZZJAZZ PHARMACEUTICALS PLC Stockput50,000$6.59Mnew
IONSIONIS PHARMACEUTICALS INC Stockcall100,000$6.54Mnew
MNKDMANNKIND CORP Stockcall1,039,500$5.58M+519,600
NVONOVO-NORDISK A S ADRput100,000$5.55Mnew
PRAXPRAXIS PRECISION MEDICINES I COM NEWput100,000$5.3Mnew
APGEAPOGEE THERAPEUTICS INC Stockcall127,400$5.06M-28,900
ROIVROIVANT SCIENCES LTD SHSput300,000$4.54Mnew
RAREULTRAGENYX PHARMACEUTICAL IN COMcall150,000$4.51M-67,000
HRMYHARMONY BIOSCIENCES HLDGS IN COMcall150,000$4.13Mnew
UPBUPSTREAM BIO INC COMMON STOCKcall200,000$3.76Mnew
SRRKSCHOLAR ROCK HLDG CORP COMcall100,000$3.72Mnew
RAREULTRAGENYX PHARMACEUTICAL IN COMput123,300$3.71M0
RXRXRECURSION PHARMACEUTICALS IN CL Acall698,400$3.41M0
SLNOSOLENO THERAPEUTICS INC COMcall50,000$3.38Mnew
ZYMEZYMEWORKS INC COMcall196,500$3.36M+17,200
MREOMEREO BIOPHARMA GROUP PLC CMNcall1,520,200$3.13M+202,600
COGTCOGENT BIOSCIENCES INC COMcall200,000$2.87M+193,100
ARCTARCTURUS THERAPEUTICS HLDGS COMput150,900$2.78Mnew
MRNAMODERNA INC COMcall102,100$2.64M0
SCPHARMACEUTICALS INCSCPHARMACEUTICALS INC COMcall462,000$2.62M-24,500
MRNAMODERNA INC COMput100,000$2.58M0
REPLREPLIMUNE GROUP INC COMMON STOCKcall612,300$2.57Mnew
ABUSARBUTUS BIOPHARMA CORP Common Shares, without par valuecall516,300$2.34Mnew
CORTCORCEPT THERAPEUTICS INC COMput26,500$2.2M-73,700
GOSSGOSSAMER BIO INC Stockcall824,800$2.17M0
CAPRCAPRICOR THERAPEUTICS INC COMMON STOCKcall300,000$2.16Mnew
ACADACADIA PHARMACEUTICALS INC COMcall89,000$1.9M+100
MBXMBX BIOSCIENCES INC Stockcall100,000$1.75Mnew
ALTALTIMMUNE INC COM NEWcall463,000$1.75M-799,900
TERNTERNS PHARMACEUTICALS INC Stockcall225,200$1.69M+64,300
OCULOCULAR THERAPEUTIX INC COMcall136,700$1.6M0
TECXTECTONIC THERAPEUTIC INC COMMON STOCKcall100,000$1.57Mnew
SMMTSUMMIT THERAPEUTICS INC COMcall74,700$1.54M0
NVAXNOVAVAX INC COM NEWcall173,500$1.5Mnew
HRMYHARMONY BIOSCIENCES HLDGS IN COMput50,100$1.38Mnew
AVXLANAVEX LIFE SCIENCES CORP COM NEWcall139,800$1.24Mnew
SKYESKYE BIOSCIENCE INC COM NEWcall300,000$1.18Mnew
CRMDCORMEDIX INC Stockput100,000$1.16Mnew
EDITEDITAS MEDICINE INC COMcall300,000$1.04Mnew
FOLDAMICUS THERAPEUTIC COMcall131,400$1.04M0
OLMAOLEMA PHARMACEUTICALS INC COMcall90,500$886Knew
PBYIPUMA BIOTECHNOLOGY INC COMMON STOCKcall135,900$722Knew
SLSSELLAS LIFE SCIENCES GROUP I COM NEWcall400,000$644K0
KODKODIAK SCIENCES INC COMcall27,800$455Knew
CRVSCORVUS PHARMACEUTICALS INC COMput50,000$368Knew
VTGNVISTAGEN THERAPEUTICS INC COMcall100,200$356K+100,000
CCCCC4 THERAPEUTICS INC COM STKcall140,700$312Knew
MLTXMOONLAKE IMMUNOTHERAPEUTICS Stockcall26,100$187Knew
RCELAVITA MEDICAL INC COMcall25,100$128Knew
ATYRATYR PHARMA INC COM NEWcall128,700$92.8K0
MREOMEREO BIOPHARMA GROUP PLC CMNput39,400$81.2K0
ATYRATYR PHARMA INC COM NEWput76,200$55K0
FLNAFILANA THERAPEUTICS INC CMNput9,900$28.8Knew
KODKODIAK SCIENCES INC COMput1,100$18Knew
Applied Therapeutics IncApplied Therapeutics Inc Common Stockcall19,000$11.5Knew
AUPHAURINIA PHARMACEUTICALS INC Stockput700$7.74Knew
TVTXTRAVERE THERAPEUTICS INC COMput300$7.17Knew
JBIOJADE BIOSCIENCES INC COM NEWput1,046$2.77Knew

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AMGNAMGEN INC62,100$17.3Mput
AMGNAMGEN INC52,100$14.5Mshares
LLYELI LILLY & CO14,816$11.5Mshares
XBISPDR SERIES TRUST100,000$8.29Mcall
LLYELI LILLY & CO10,000$7.8Mcall
RVMDREVOLUTION MEDICINES INC200,000$7.36Mcall
NVONOVO-NORDISK A S100,000$6.9Mcall
SPRYARS PHARMACEUTICALS INC280,700$4.9Mcall
PFEPFIZER INC200,000$4.85Mcall
VRTXVERTEX PHARMACEUTICALS INC10,000$4.45Mshares
GILDGILEAD SCIENCES INC30,000$3.33Mshares
ARGXARGENX SE5,974$3.29Mshares
SRRKSCHOLAR ROCK HLDG CORP62,926$2.23Mshares
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INC206,200$2.06Mshares
MLTXMOONLAKE IMMUNOTHERAPEUTICS41,300$1.95Mput
VRDNVIRIDIAN THERAPEUTICS INC122,061$1.71Mshares
MRKMERCK & CO INC20,000$1.58Mshares
Reviva Pharmaceuticals Hold…Reviva Pharmaceuticals Holdings I…4,000,000$1.52Mcall
QUREUNIQURE NV104,100$1.45Mcall
COGTCOGENT BIOSCIENCES INC201,400$1.45Mput
BHVNBIOHAVEN LTD100,000$1.41Mcall
OLMAOLEMA PHARMACEUTICALS INC253,657$1.08Mshares
SMMTSUMMIT THERAPEUTICS INC50,000$1.06Mput
CAPRCAPRICOR THERAPEUTICS INC106,600$1.06Mput
BMEABIOMEA FUSION INC568,900$1.02Mcall
TNGXTANGO THERAPEUTICS INC200,000$1.02Mcall
89BIO INC89BIO INC98,382$966Kshares
SCPHARMACEUTICALS INCSCPHARMACEUTICALS INC217,623$829Kshares
ARVNARVINAS INC96,455$710Kshares
ALTALTIMMUNE INC171,400$663Kput
CRDFCARDIFF ONCOLOGY INC208,100$656Kcall
PRTAPROTHENA CORP PLC100,000$607Kcall
PHATPHATHOM PHARMACEUTICALS INC40,294$386Kshares
NUVLNUVALENT INC5,000$382Kshares
REPLREPLIMUNE GROUP INC32,483$302Kshares
ELDNELEDON PHARMACEUTICALS INC64,613$175Kshares
ELEVATION ONCOLOGY INC COMELEVATION ONCOLOGY INC COM362,935$133Kshares
NKTRNEKTAR THERAPEUTICS47,474$85.9Kcall
SMMTSUMMIT THERAPEUTICS INC932$19.8Kshares
ZLABZAI LAB LTD3,785$13.2Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001892688-25-000193 base2025-11-14acceptance time not in the bulk data set